{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01728727",
      "OrgStudyIdInfo": {
        "OrgStudyId": "20120912-3"
      },
      "Organization": {
        "OrgFullName": "Air Force Military Medical University, China",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis",
      "OfficialTitle": "Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "November 2012",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 2012"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 2014",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "September 2015",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "October 31, 2012",
      "StudyFirstSubmitQCDate": "November 13, 2012",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "November 20, 2012",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "November 13, 2012",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "November 20, 2012",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Han Ying",
        "ResponsiblePartyInvestigatorTitle": "professor",
        "ResponsiblePartyInvestigatorAffiliation": "Air Force Military Medical University, China"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Air Force Military Medical University, China",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "The Second Affiliated Hospital of Chongqing Medical University",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Eastern Hepatobiliary Surgery Hospital",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Chinese Academy of Medical Sciences",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Fudan University",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "HBV related Liver disease is a common medical problem in China. An estimated 7.18% of the Chinese (about 93 million) is infected with hepatitis B, and most of the HBV- related hepatitis can developed into liver cirrhosis.\n\nLiver transplantation is the only available life saving treatment for patients with end stage liver disease. However, lack of donors, surgical complications, rejection, and high cost are serious problems.\n\nMesenchymal stem cells (MSCs) possess plasticity and have the potential to differentiate into hepatocyte; Thus, MSCs hold great hope for therapeutic applications. Human umbilical cord-derived MSCs (hUC-MSCs) exhibit a more beneficial immunogenic profile and greater overall immunosuppressive potential than aged bone marrow-derived MSCs. Like MSCs derived from bone marrow, hUC-MSCs can also be used to treat rat liver fibrosis and improve glucose homeostasis in rats with liver cirrhosis. In this study, the patients with HBV-related liver cirrhosis will undergo administration of hUC-MSCs via hepatic artery to evaluate the safety and efficacy of hUC-MSC treatment for these patients."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Liver Cirrhosis",
          "End Stage Liver Disease"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "liver cirrhosis",
          "end stage liver disease",
          "umbilical cord",
          "mesenchymal stem cells",
          "HBV"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "240",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "conventional",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "conventional treatment & antiviral treatment",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: conventional treatment"
              ]
            }
          },
          {
            "ArmGroupLabel": "UC-MSC transplantation",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Participants will receive umbilical cord derived mesenchymal stem cell treatment at day 1 and conventional treatment and antiviral treatment through the one year study visit. Participants will then be followed until one years study visit",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: UC-MSC transplantation"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "UC-MSC transplantation",
            "InterventionDescription": "After enrolled, Participant will receive umbilical cord MSC transplantation of 1*10E6 cells/kg via hepatic artery. Participant will then be followed until 1 years study visit",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "UC-MSC transplantation"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "conventional treatment",
            "InterventionDescription": "Participants will receive conventional treatment and antiviral treatment.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "conventional"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "one year survival rate",
            "PrimaryOutcomeTimeFrame": "one year after treatment"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "MELD score",
            "SecondaryOutcomeTimeFrame": "1week, 4weeks,3months, 6months, 9months and 1year after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "Child Pugh Score",
            "SecondaryOutcomeTimeFrame": "1week, 4weeks,3months, 6months, 9months and 1year after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "alpha fetoprotein",
            "SecondaryOutcomeTimeFrame": "1week, 4weeks,3months, 6months, 9months and 1year after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "renal function",
            "SecondaryOutcomeTimeFrame": "1week, 4weeks,3months, 6months, 9months and 1year after treatment"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAged 18-65 years\nHBV-related liver cirrhosis\nChild-Pugh score 9-15\nWritten consent -\n\nExclusion Criteria:\n\nHepatocellular carcinoma or other malignancies\nSevere problems in other vital organs(e.g.the heart,renal or lungs)\nPregnant or lactating women\nSevere bacteria infection\nAnticipated with difficulty of follow-up observation\nOther candidates who are judged to be not applicable to this study by doctors",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "ying han",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "86-29-84771539",
            "CentralContactEMail": "hanying@fmmu.edu.cn"
          },
          {
            "CentralContactName": "yongquan shi",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "86-29-84771515",
            "CentralContactEMail": "shiyquan@fmmu.edu.cn"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Daiming Fan",
            "OverallOfficialAffiliation": "Air Force Military Medical University, China",
            "OverallOfficialRole": "Study Chair"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Xijing Hospital of Digestive Disease",
            "LocationStatus": "Recruiting",
            "LocationCity": "Xi'an",
            "LocationState": "Shaanxi",
            "LocationZip": "710032",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Ying Han",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "86-29-84771539",
                  "LocationContactEMail": "hanying@fmmu.edu.cn"
                },
                {
                  "LocationContactName": "Yongquan Shi",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "86-29-84771515",
                  "LocationContactEMail": "shiyquan@fmmu.edu.cn"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000008103",
            "ConditionMeshTerm": "Liver Cirrhosis"
          },
          {
            "ConditionMeshId": "D000008107",
            "ConditionMeshTerm": "Liver Diseases"
          },
          {
            "ConditionMeshId": "D000058625",
            "ConditionMeshTerm": "End Stage Liver Disease"
          },
          {
            "ConditionMeshId": "D000005355",
            "ConditionMeshTerm": "Fibrosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000004066",
            "ConditionAncestorTerm": "Digestive System Diseases"
          },
          {
            "ConditionAncestorId": "D000017093",
            "ConditionAncestorTerm": "Liver Failure"
          },
          {
            "ConditionAncestorId": "D000048550",
            "ConditionAncestorTerm": "Hepatic Insufficiency"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M10259",
            "ConditionBrowseLeafName": "Liver Diseases",
            "ConditionBrowseLeafAsFound": "Liver Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10255",
            "ConditionBrowseLeafName": "Liver Cirrhosis",
            "ConditionBrowseLeafAsFound": "Liver Cirrhosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M28321",
            "ConditionBrowseLeafName": "End Stage Liver Disease",
            "ConditionBrowseLeafAsFound": "End Stage Liver Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M7637",
            "ConditionBrowseLeafName": "Fibrosis",
            "ConditionBrowseLeafAsFound": "Cirrhosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8035",
            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6407",
            "ConditionBrowseLeafName": "Digestive System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M18567",
            "ConditionBrowseLeafName": "Liver Failure",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M25123",
            "ConditionBrowseLeafName": "Hepatic Insufficiency",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC06",
            "ConditionBrowseBranchName": "Digestive System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M10262",
            "InterventionBrowseLeafName": "Liver Extracts",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3466",
            "InterventionBrowseLeafName": "Antiviral Agents",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Hemat",
            "InterventionBrowseBranchName": "Hematinics"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          },
          {
            "InterventionBrowseBranchAbbrev": "Infe",
            "InterventionBrowseBranchName": "Anti-Infective Agents"
          }
        ]
      }
    }
  }
}